drug

brexpiprazole

1 story · latest Jul 13, 2026

Status: FDA approved Jul 2015 · NDA205422
Brand: Rexulti

Relationships

Developed by Otsuka Pharmaceutical

Timeline

IGC Pharma discloses updated CALMA Phase 2 data in investor presentation

Jul 13Clinical readoutIGC Pharma, LLC

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.